Douleur Therapeutics is a clinical stage biopharmaceutical company founded by physician scientist Krishnan Chakravarthy in 2018 that is focused on revolutionizing the treatment of neuropathic pain. The company is headquartered in San Diego, CA. Our lead compound DT-001 is a non-opiate Toll-Like Receptor (TLR-4) antagonist that has completed phase 1 clinical trials. We are advancing the application of intrathecal and intravenous use of DT-001 in the acute and persistent post-operative pain market.
Company Details
- Employees
- 3
- Address
- 10225 Barnes Canyon Rd, San Diego,california 92121,united States
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- https://www.douleurtx.com
- Keywords
- Clayton.
- HQ
- San Diego, California
Douleur Therapeutics Questions
Douleur Therapeutics's website is https://www.douleurtx.com
Douleur Therapeutics's LinkedIn profile is https://www.linkedin.com/company/douleur-therapeutics
Douleur Therapeutics has
3 employees.
View email and phone details for 3
employees at Douleur Therapeutics.
Douleur Therapeutics's industry is
Pharmaceutical Manufacturing
Douleur Therapeutics's top competitors are
Solaris Research Institute,
Cari Health,
Payoneer,
Nxtstim,
Gener8tor,
Accufix Medical,
Navega Therapeutics,
Innovative Pain Treatment Solutions.
Douleur Therapeutics's categories are Pharmaceutical Manufacturing
